Benzinga | Feb 16, 2021 04:02PM EST

CRISPR Therapeutics Q4 Net Loss $107M vs Net Income $30.5M In Same Qtr. Last Year, Sales $200.00K Down From $77.02M YoY

CRISPR Therapeutics (NASDAQ:CRSP) reported $200.00 thousand in sales this quarter. This is a 99.74 percent decrease over sales of $77.02 million the same period last year.